HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Cuffie-Jackson Selected Research

1,4- bis(4- methoxyphenyl)- 3- (3- phenylpropyl)- 2- azetidinone

1/2001Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Cuffie-Jackson Research Topics

Disease

2Hypercholesterolemia
08/2001 - 01/2001

Drug/Important Bio-Agent (IBA)

2LipidsIBA
08/2001 - 01/2001
1Pharmaceutical PreparationsIBA
08/2001
1Ezetimibe (Zetia)FDA Link
08/2001
11,4- bis(4- methoxyphenyl)- 3- (3- phenylpropyl)- 2- azetidinoneIBA
01/2001
1CholesterolIBA
01/2001
1LDL CholesterolIBA
01/2001